Agathos Biologics launches recombinant adeno-associated virus production service using novel AE1-BHK cell line
Agathos Biologics, a leading biotechnology company in genetic medicine, announced today the launch of its recombinant adeno-associated virus (rAAV) production service using the company’s novel proprietary cell line, AE1-BHK.